Obstetrics & Gynecology · San Francisco, CA
NPI
1942358577
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3838 California St Rm 412
San Francisco, CA, 94118
Phone (415) 349-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,829
138 services
Medicare patients, 2024
76
Average age 73
Drug cost, 2024
$123K
604 prescriptions
Company payments, 2025
$178
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel H Shu was code 99213 (office e&m - established), 78 times for 47 patients. In total Rachel H Shu billed 138 services in 9 codes, and Medicare paid $8,829.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 78 | 47 | $68.21 | $5,320 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 36 | 36 | $47.39 | $1,706 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 14 | 14 | $56.74 | $794 |
By year: 2022 $12K for 173 services; 2023 $10K for 144 services; 2024 $8,829 for 138 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel H Shu prescribed most often to Medicare patients was Alendronate Sodium, with 84 prescriptions and refills. In total Rachel H Shu wrote 604 Medicare prescriptions that cost $123K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 84 | 229 | 29 | $855 |
| Amlodipine Besylate Generic | 65 | 168 | 17 | $414 |
| Imvexxy Estradiol | 54 | 139 | 22 | $31K |
| Atorvastatin Calcium Generic | 49 | 117 | 14 | $504 |
| Levothyroxine Sodium Generic | 32 | 92 | 11 | $406 |
| Estradiol Generic | 30 | 64 | 12 | $4,789 |
| Raloxifene Hcl Generic | 27 | 79 | Under 11 | $1,806 |
| Prolia Denosumab | 24 | 144 | 13 | $42K |
| Estring Estradiol | 21 | 62 | Under 11 | $11K |
| Valacyclovir Valacyclovir Hcl | 14 | 30 | Under 11 | $1,549 |
| Estradiol (Twice Weekly) Estradiol | 13 | 36 | Under 11 | $1,330 |
| Yuvafem Estradiol | 13 | 22 | Under 11 | $1,634 |
| Synthroid Levothyroxine Sodium | 12 | 34 | Under 11 | $892 |
| Amitriptyline Hcl Generic | 12 | 20 | Under 11 | $55.22 |
Brand drugs: - claims; generic drugs: 433 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel H Shu $178 ($178 in general payments such as food, travel and fees) from 4 companies. The largest payer was Astellas Pharma US Inc with $80.59.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.